Subsequently, a cell cycle-dependent kinase inhibitor target gene (CDKNIA; encodes p21) present downstream of TP53 has been known to be capable of promoting apoptosis in a variety of tumor types by either activating the TNF receptor or generating the proapoptotic protein bcl2 [51,52]. The gene discussed is CDKN1A; the disease is neoplasm.